Vortioxetine
- Generic Name
- Vortioxetine
- Brand Names
- Brintellix, Trintellix
- Drug Type
- Small Molecule
- Chemical Formula
- C18H22N2S
- CAS Number
- 508233-74-7
- Unique Ingredient Identifier
- 3O2K1S3WQV
- Background
Vortioxetine is an antidepressant medication indicated for the treatment of major depressive disorder (MDD). It is classified as a serotonin modulator and stimulator (SMS) as it has a multimodal mechanism of action towards the serotonin neurotransmitter system whereby it simultaneously modulates one or more serotonin receptors and inhibits the reuptake of se...
- Indication
用于治疗重度抑郁症成人患者。
- Associated Conditions
- Major Depressive Disorder (MDD)
- Associated Therapies
- -
Study of Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder
- First Posted Date
- 2008-08-08
- Last Posted Date
- 2013-12-18
- Lead Sponsor
- Takeda
- Target Recruit Count
- 457
- Registration Number
- NCT00731120
Efficacy of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-08-08
- Last Posted Date
- 2013-12-18
- Lead Sponsor
- Takeda
- Target Recruit Count
- 781
- Registration Number
- NCT00730691
Safety and Tolerability of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder
- First Posted Date
- 2008-07-02
- Last Posted Date
- 2013-12-13
- Lead Sponsor
- Takeda
- Target Recruit Count
- 836
- Registration Number
- NCT00707980
Efficacy and Safety of Vortioxetine (Lu AA21004) in the Treatment of Patients With Major Depressive Disorder
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-05-06
- Last Posted Date
- 2013-12-18
- Lead Sponsor
- Takeda
- Target Recruit Count
- 611
- Registration Number
- NCT00672620
Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Adults With Major Depressive Disorder
- First Posted Date
- 2008-05-06
- Last Posted Date
- 2013-12-13
- Lead Sponsor
- Takeda
- Target Recruit Count
- 600
- Registration Number
- NCT00672958
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath